Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both T(h)1 and T(h)2 cytokines

International Immunology

Volumn 9, Issue 5, 1997, Pages 679-687

  Tang, Haiwen ^a   Braley Mullen, Helen ^a  

^a University of Missouri   (United States)

Author keywords

Autoimmune diseases; Cytokine gene mRNA; Tolerance

Indexed keywords

AUTOANTIBODY; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; GENE EXPRESSION; GRANULOMATOSIS; HASHIMOTO DISEASE; HELPER CELL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYROID GLAND;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GRANULOMA; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED CBA; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 0030926038     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.5.679     Document Type: Article

References (45)

1. Vladutiu, A. O. and Rose, N. R. 1971. Autoimmune murine thyroiditis: relation to histocompatibility (H-2) type. Science 174:1137.
2. Charreire, J. 1989. Immune mechanisms in autoimmune thyroiditis. Adv. Immunol. 46:263.
3. Okayasu, I., Kong, Y. M., David, C. S. and Rose, N. R. 1981. In vitroT-lymphocyte proliferate response to mouse thyroglobulin in experimental autoimmune thyroiditis. Cell. Immunol. 61:32.
4. Braley-Mullen, H., Johnson, M., Sharp, G. C. and Kyriakos, M. 1985. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell. Immunol. 93:132.
5. Braley-Mullen, H., Sharp, G. C., Bickel, J. T. and Kyriakos, M. 1991. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. J. Exp. Med. 173:899.
6. Stull, S. J., Sharp, G. C., Kyriakos, M., Bickel, J. T. and Braley-Mullen, H. 1992. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-γ antibody. J. Immunol. 149:2219.
7. Weigle, W. O. 1973. Immunological unresponsiveness. Adv. Immunol. 16:61.
8. Kennedy, M. K., Dal Canto, M. C., Trotter, J. L. and Miller, S. D. 1988. Specific immune regulation of chronic relapsing experimental allergic encephalomyelitis in mice. J. Immunol. 141:2986.
9. Gregorian, S. K., Clark, L., Heber-Katz, E., Amento, E. P. and Rostami, A. 1993. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell. Immunol. 150:298.
10. Kong, Y. M., Okayasu, I., Giraldo, A. A., Beisel, K. W., Sundick, R. S., Rose, N. R., David, C. S., Audibert, F. and Chedid, L. 1982. Tolerance to thyroglobulin by activating suppressor mechanisms. Ann. NY Acad. Sci. 392:191.
11. Mosmann, T. R., Cherwinski, H., Bond, M W., Giedlin, M. A. and Coffman, R. L. 1986. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
12. h1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
13. h1) cells. J. Immunol. 148:3687.
14. h2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. immunol. 23:46.
15. De Wit, D., Van Mechelen, M., Ryelandt, M., Figueiredo, A. C., Abramowicz, D., Goldman, M., Bazin, H., Urbain, J. and Leo, O. 1992. Injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175:9.
16. + T cell subsets. J. Exp. Med. 178:1673.
17. Rochen, M., Urban, J. and Shevach, E. M. 1994. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1885.
18. + T cells. Cell. immunol. 153:492.
19. Snapper, C. M. and Paul, W. E. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
20. Paul, W. E. and Seder, R. A. 1994. Lymphocyte responses and cytokines. Cell 76:241
21. Mohler, K. M. and Butler, L. D. 1990. Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J. Immunol. 145:1734.
22. O'Garra, A. and Vieira, P. 1992. Polymerase chain reaction for detection of cytokine gene expression. Curr. Opin. Immunol. 4:211.
23. Sugihara, S., Fujiwara, H. and Shearer, G. M. 1993. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions. J. Immunol. 150:683.
24. Romball, C. G. and Weigle, W. O. 1987. Transfer of experimental autoimmune thyroiditis with T cell clones. J. Immunol. 138:1092.
25. Stull, S. J., Kyriakos, M., Sharp, G. C. and Braley-Mullen, H. 1988. Prevention and reversal of experimental autoimmune thyroiditis in mice by administration of anti-L3T4 monoclonal antibody. Cell. Immunol. 177:188.
26. + cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell. Immunol. 122:377.
27. Van Parijs, L., Ibraghimov, A. and Abbas, A. K. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
28. Romball, C. G. and Weigle, W. O. 1988. Characteristics of T cell clones that transfer experimental autoimmune thyroiditis to recipient mice. FASEB J. 2:A909(Abstr.).
29. Parish, N. M., Roitt, I. M. and Cooke, A. 1988. Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Eur J. Immunol. 18:1463.
30. + cells as mediators of both thyroglobulin-activated and TSH-induced suppression. Clin. Immunol. Immunopathol. 51:38.
31. Peterson, K. E. and Braley-Mullen, H. 1995. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell. Immunol. 166:123.
32. Liu, G. Y. and Wraith, D. C. 1995. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice-implications for autoimmunity. Int. Immunol. 8:1255.
33. Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L. and Miller, S. D. 1995. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.
34. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
35. McMurray, R. W., Tang, H. and Braley-Mullen, H. 1996. The role of α4 integrin and intercellular adhesion molecule-1 (ICAM-1) in murine experimental autoimmune thyroiditis. Autoimmunity 23:9.
36. Miller, J. F. and Morahan, G. 1992. Peripheral T cell tolerance. Annu. Rev. Immunol. 10:51.
37. Weiner H. L., Friedman, A., Miller, A., Khoury, S. J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E. and Hafler, D. A. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
38. Aichele, P., Kyburz, D., Ohashi, P. S., Odermatt, B., Zinkernagel, R. M., Hengartner, H. and Pircher, H. 1994. Peptide-induced T cell tolerance to prevent autoimmune disease in a transgenic mouse model. Proc. Natl Acad. Sci. USA 901:444.
39. Braley-Mullen, H., Tompson, J. G., Sharp, G. C. and Kyriakos, M. 1980. Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells. Cell. Immunol. 51:408.
40. Braley-Mullen, H., Tompson, J. G., Sharp, G. C. and Kyriakos, M. 1983. Effect of guinea pig thyroglobulin in incomplete Freund's adjuvant on experimental autoimmune thyroiditis induced by in vitro-activated lymph node cells. Cell. Immunol. 76:113.
41. Jenkins, M. K. and Schwartz, R. H. 1987. Antigen presentation by chemically-modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
42. h2 cytokine responses. Int. Immunol. 6:761.
43. Gaur, A., Brook, W., Liu, A., Rothbard, J. and Fathman, C. G. 1992. Amelioration of autoimmune encephalomyelitis by myelin protein synthetic peptide-induced anergy. Science 258:1491.
44. Saoudi, A., Simmonds, S., Huitinga, I. and Mason, D. 1995. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells, evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 182:335.
45. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P, J., Wraith, D. C., O'Garra, A., Garrison Fathman, C. and Steinman, L. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.